Characteristics of HCV positive patients in an Italian urban psychiatric unit
Tóm tắt
1) to assess the prevalence of hepatitis C virus (HCV) infection in a population of acute psychiatric in-patients; 2) to find out relationships between HCV comorbidity and clinical features of psychiatric patients. Prospective observational study in a 6-year period. 2396 cases (1492 patients) were admitted in the considered period. Forty-two patients (2.8%) were affected by HCV infection. HCV infection was more frequent in patients with less years of education, lower social class, lower last year best Global Assessment of Functioning score, more hostile or violent behavior in hospital, with a lifetime history of previous suicide attempt, and with substance-related disorders. HCV infection in psychiatric patients constitutes a major threat to the health of psychiatric patients and is related with unfavorable social background, worse global functioning, hostile or violent behavior, substance-related disorders. It appears also to be a significant risk of suicidal behavior.
Tài liệu tham khảo
Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP: Medical comorbidity in schizophrenia. Schizophr Bull. 1996, 22: 413-430.
Hewer W, Rossler W: Mortality of patients with functional psychiatric illnesses during inpatient treatment. Fortschr Neurol Psychiatr. 1997, 65: 171-181.
Zubenko GS, Marino LJ, Sweet RA, Rifai AH, Mulsant BH, Pasternak RE: Medical comorbidity in elderly psychiatric inpatients. Biol Psychiatry. 1997, 41: 724-736. 10.1016/S0006-3223(96)00337-X.
Reeves RR, Torres RA: Exacerbation of psychosis by misinterpretation of physical symptoms. South Med J. 2003, 96: 702-704. 10.1097/01.SMJ.0000078686.34109.11.
Farmer S: Medical problems of chronic psychiatric patients in a community support program. Hosp Comm Psychiatry. 1987, 38: 745-749.
Woo BK, Daly JW, Allen EC, Jeste DV, Sewell DD: Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. J Geriatr Psychiatry Neurol. 2003, 16: 121-125. 10.1177/0891988703016002011.
Black DW: Iowa record-linkage study: death rates in psychiatric patients. J Affect Disord. 1998, 50: 277-282. 10.1016/S0165-0327(98)00019-6.
Dembling B: Mental disorder as a contributing cause of death in the U.S. in 1992. Psychiatr Serv. 1997, 48: 45-
Dembling BP, Chen DT, Vachon L: Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999, 50: 1036-1042.
Felker B, Yazel JJ, Short D: Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv. 1996, 47: 1356-1363.
Harris EC, Barrablough B: Excess mortality of mental disorder. Br J Psychiatry. 1998, 173: 11-53.
Stroup TS, Gilmore JH, Jarskog LF: Management of medical illnesses in persons with schizophrenia. Psychiatr Ann. 2000, 30: 35-40.
Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS, Essock SM, Butterfield MI, Marsh BJ, Five-Site Health and Risk Study Research Committee: The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv. 2003, 54: 827-835. 10.1176/appi.ps.54.6.827.
Desenclos JC: Epidemiology of hepatitis C. Rev Prat. 2000, 50: 1066-1070.
Memon MI, Memon MA: Hepatitis C: an epidemiological review. J Viral Hepat. 2002, 9: 84-100. 10.1046/j.1365-2893.2002.00329.x.
Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Cap P: The prevalence of hepatitis C in England and Wales. J Infect. 2002, 45: 219-226. 10.1053/jinf.2002.1059.
Williams I: Epidemiology of hepatitis C in the United States. Am J Med. 1999, 107 (6B): 2S-9S. 10.1016/S0002-9343(99)00373-3.
Davidson S, Judd F, Folley D, Hocking B, Thompson S, Hyland B: Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust N Z J Psychiatry. 2001, 35: 203-209. 10.1046/j.1440-1614.2001.00867.x.
El-Serag HB, Kunik M, Richardson P, Rabeneck L: Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002, 123: 476-482. 10.1053/gast.2002.34750.
Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, Constantine NT: Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003, 44: 293-302. 10.1016/S0010-440X(03)00094-4.
Cividini A, Pistorio A, Regazzetti A, Cerino A, Tinelli C, Mancuso A, Ribola M, Galli ML, Agnusdei A, Leone M, Silini E, Mondelli MU: Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol. 1997, 27: 455-463. 10.1016/S0168-8278(97)80348-0.
Nguyen HA, Miller AI, Dieperink E, Willenbring ML, Tetrick LL, Durfee JM, Ewing SL, Ho SB: Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterology. 2002, 97: 1813-1820. 10.1111/j.1572-0241.2002.05800.x.
Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, Constantine NT, Wolford GL, Salyers MP: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001, 91: 31-37.
Dinwiddie SH, Shicker L, Newman T: Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry. 2003, 160: 172-174. 10.1176/appi.ajp.160.1.172.
Morrison EF: A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hosp Commun Psychiatry. 1992, 43: 505-506.
Fernandez-Egea E, Gomez Gil E, Corbella Santoma B, Salamero Baro M, Blanch Andreu J, Vades Miyar M: Serological testing and prevalence of human immunodeficiency, hepatitis B and C viruses infections among acute psychiatric inpatients. Med Clin (Barc). 2002, 119: 690-692.
Alter MJ, Kruszon-Moran D, Nainan OV, Mc Quillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Eng J Med. 1999, 341: 556-562. 10.1056/NEJM199908193410802.
Osher FC, Goldberg RW, McNary SW, Swartz MS, Essock SM, Butterfield MI, Rosenberg SD, the Five-Site Health and Risk Study Research Committee: Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatr Serv. 2003, 54: 842-847. 10.1176/appi.ps.54.6.842.
Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC, Goodman LA, Swanson JW, Bastian LA, Horner RD, Five-Site Health and Risk Study Research Committee: Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv. 2003, 54: 848-853. 10.1176/appi.ps.54.6.848.
Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V, Clotet B, Sabria M, Foz M: Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Br Med J. 1990, 301: 1130-1133.
Fiscus SA, Kelly WF, Battigelli DA, Weber DJ, Schoenbach VJ, Landis SE, Wilber JC, Van der Host CM: Hepatitis C virus seroprevalence in clients of sexually transmitted disease clinics in North Carolina. Sex Transm Dis. 1994, 21: 155-160.
Cilla G, Perez-Trallero E, Iturriza M, Arrizabalaga J, Iribarren JA: Possibility of heterosexual transmission of hepatitis C virus. Eur J Microbiol Infect Dis. 1991, 10: 533-534. 10.1007/BF01963948.
Salvaggio A, Conti M, Albano A, Pianetti A, Muggiasca ML, Re M, Selvaggio L: Sexual transmission of hepatitis C virus and HIV-1 infection in intravenous drug users. Eur J Epidemiology. 1993, 9: 279-284. 10.1007/BF00146264.
Sladden TJ, Hickey AR, Dunn TM, Beard Jr: Hepatitis C transmission on the north coast of New South Wales: explaining the unexplained. Med J Australia. 1997, 166: 290-293.
Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report. 1998, 47 (RR-19): 1-39.
Hershow RC, Kalish LA, Sha B, Till M, Cohen M: Hepatitis C virus infection in Chicago women with or at risk for HIV infection. Sex Transm Dis. 1998, 25: 527-532.
Ward H, Pallecaros A, Green A, Day S: Health issues associated with increasing use of "crack" cocaine among female sex workers in London. Sex Transm Infect. 2000, 76: 292-293. 10.1136/sti.76.4.292.
Marsano LS, Pena LR: The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology. 1998, 45: 331-339.
Corrao G, Carle F, Lepore AR, Zepponi E, Galatola G, Di Orio F: Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: a case-controlled study. Eur J Epidemiol. 1992, 9: 634-639. 10.1007/BF00145376.
Stuyt EB: Hepatitis C in patients with co-occurring mental disorders and substance use disorders: is tobacco use a possible risk factor?. Am J Addiction. 2004, 13: 46-52. 10.1080/10550490490265316.
Dieperink E, Willenbring M, Ho SB: Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry. 2000, 157: 867-876. 10.1176/appi.ajp.157.6.867.
Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N: Assessment of long term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 2000, 32: 582-587. 10.1053/jhep.2000.9714.
Janssen HL, Brouwer JT, van der Mast RC, Schalm SW: Suicide associated with alfa-interferon therapy for chronic hepatitis. J Hepatol. 1994, 21: 241-243. 10.1016/S0168-8278(05)80402-7.
Bourat L, Larrey D, Michel H: Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases. Gastroenterol Clin Biol. 1995, 19: 1063-
Rifflet H, Vuillemin E, Oberti F, Duverger P, Laine P, Garre JB, Cales P: Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha. Gastroenterol Clin Biol. 1998, 22: 353-357.
Fukunishi K, Tanaka H, Maruyama J, Takahashi H, Kitagishi H, Ueshima T, Maruyama K, Sakata I: Burns in a suicide attempt related to psychiatric side effects of interferon. Burns. 1998, 24: 581-583. 10.1016/S0305-4179(98)00073-4.
Pardelli R, Vivaldi I, Maccanti O, Sani S, Menicagli V: Attempted suicide during interferon therapy: a case report and literature review. Infez Med. 1998, 6: 221-224.
Windemuth D, Bacharach-Buhles M, Hoffman K, Altmeyer P: Depression and suicidal intentions as a side effect of high dosage of interferon-alpha therapy: two cases. Hautarzt. 1999, 50: 266-269. 10.1007/s001050050899.
Kovacs A, Szomor A, Abraham I, Nagy F, Losonczy H: Orv Hetil. 2002, 143: 2183-2187.